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ABSTRACT
A significant increase in the isolation frequency of ciprofloxacin-resistant Escherichia coli was observed in
the haematology departments of two university hospitals in The Netherlands. Amplified fragment
length polymorphism analysis revealed that this increase was not caused by the emergence of unique
ciprofloxacin-resistant clones. Determination of the presence of class 1 integrons indicated that 81% of
the ciprofloxacin-resistant isolates contained an intI1 gene, compared with 11% of the ciprofloxacin-
susceptible isolates (p < 0.0001). The quinolone resistance gene qnrA was not present in any of the
integrons characterised and could not be detected using dot-blot hybridisation of total DNA. In addition,
conjugation experiments showed that ciprofloxacin resistance was not co-transferred with class 1
integrons. Ciprofloxacin-resistant isolates harboured mutations in the gyrA gene, which are known to
encode ciprofloxacin resistance. In conclusion, an association was observed between ciprofloxacin
resistance and the presence of class 1 integrons, which could not be explained by the currently known
genetic determinants of quinolone resistance.
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INTRODUCTION
Multidrug resistance among Enterobacteriaceae
can be acquired and spread vertically through
chromosomal mutations in a resident gene, or by
the acquisition of resistance genes following
horizontal gene transfer. During 2000, a signifi-
cant increase in the isolation frequency of ciprofl-
oxacin- and co-trimoxazole-resistant Escherichia
coli was observed in the haematology wards of
two Dutch hospitals. This increase could have
been caused by the clonal spread of one particular
resistant strain, or through horizontal gene trans-
fer [1–6]. Specialised transposon-like genetic
structures, termed integrons, appear to play an
increasing role in the development of resistance in
Enterobacteriaceae in hospital settings. Two plas-
mid-borne quinolone resistance genes associated
with integron-like structures have been identified
recently. The qnrA gene confers low-level resist-
ance to ciprofloxacin in several species of Entero-
bacteriaceae [7–13], and the qnrS gene, which
confers low-level quinolone resistance in E. coli,
has been found on a transferable plasmid in a
clinical isolate of Shigella flexneri 2b [14]. How-
ever, the most important mechanism of resistance
to fluoroquinolones (including ciprofloxacin)
involves chromosomal mutations in the genes
encoding DNA gyrase (gyrA) and topoisomerase
IV (parC). Eight different mutations in gyrA cause
ciprofloxacin resistance, with mutations altering
amino-acids 83 or 87, or both, being observed
most frequently [15]. Decreased sensitivity caused
by active efflux of quinolones has also been
described for E. coli, usually in combination with
mutations in gyrA and ⁄ or parC [16].
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The present study aimed to determine the
origin and nature of the increase in ciprofloxa-
cin resistance in two Dutch hospitals. All
isolates were subjected to DNA fingerprinting
by amplified fragment length polymorphism
(AFLP) analysis [17,18] to determine whether
clonal spread of a single strain had occurred.
The presence of class 1 and 2 integrons, qnrA
and mutations in gyrA were determined, and
transfer of antibiotic resistance was studied.
MATERIALS AND METHODS
Bacteria and prophylactic regimens
In total, 161 isolates of E. coli, collected between 2000 and 2002,
were included in the study (Table 1). Twenty-one ciprofloxa-
cin-resistant isolates were obtained from consecutive patients
treated in the haematology ward of the VU University Medical
Center (Amsterdam, The Netherlands) during this period.
Ciprofloxacin-susceptible E. coli (n = 79) isolates were obtained
from consecutive patients admitted to the same ward during
the same period. Prophylactic selective decontamination of the
digestive tract of the haematological patients consisted of
ciprofloxacin (two daily oral doses of 500 mg) and tobramycin
(three daily oral doses of 80 mg). Colistin (three daily oral
doses of 300 mg) or co-trimoxazole (three daily oral doses of
960 mg) were added to the regimen for patients colonised with
resistant Gram-negative bacteria.
In addition, 33 ciprofloxacin-resistant E. coli isolates were
obtained from consecutive patients treated in the haematology
ward of the Erasmus University Medical Center (Rotterdam,
The Netherlands), where the selective decontamination regi-
men consisted of ciprofloxacin (1000 mg ⁄day orally or
800 mg ⁄day intravenously). For patients colonised with
ciprofloxacin-resistant Gram-negative bacteria, the prophylac-
tic regimen was changed to ciprofloxacin (two daily oral doses
of 500 mg or two daily intravenous doses of 400 mg) in
combination with colistin (as a mouthwash, 1 mg ⁄mL, four-
times-daily, combined with four daily oral doses of 200 mg)
and tobramycin (three daily doses of 80 mg ⁄ 2 mL). Patients
were treated with prophylactic therapy for c. 3 weeks during
each neutropenic period. All E. coli isolates from haematolog-
ical patients were from anal swabs obtained for surveillance
purposes. Finally, 28 ciprofloxacin-resistant E. coli isolates
were collected randomly from various clinical specimens and
wards of the Erasmus University Medical Center and the VU
University Medical Center.
Identification of the 161 isolates was with the Vitek 1 system
(bioMe´rieux, Marcy l’Etoile, France). Susceptibility to cipro-
floxacin, co-trimoxazole, gentamicin and amoxycillin was
tested by the disk-diffusion method on Mueller–Hinton agar
(Difco; Becton Dickinson, Franklin Lakes, NJ, USA) with
Neosensitabs (Rosco, Taastrup, Denmark) according to NCCLS
criteria [17]. E. coli J53 (pMG252) [7] was a gift from G. A.
Jacoby (Lahai Clinic, Burlington, MA, USA).
Purification of DNA and typing by AFLP analysis
Total DNA was extracted from E. coli isolates with a MagNA
Pure LC Instrument, using the MagNA Pure LC DNA isolation
Kit III for bacteria and fungi (Roche Diagnostics, Almere, The
Netherlands) according to the manufacturer’s recommenda-
tions. Extracted DNA was dissolved in 100 lL of TE buffer
(10 mM Tris, 1 mM EDTA, pH 8.0), aliquoted and stored at
) 20C. All isolates were typed by AFLP [18,19]. After
restriction and amplification, the DNA fragments were separ-
ated on an ABI Prism 3100 Genetic Analyser (Applied
Biosystems, Warrington, UK), after which the data were
analysed with the Pearson correlation coefficient and clustered
by unweighted pair-group matrix analyses (UPGMA) using
BioNumerics software, v. 3.0 (Applied Maths, St-Martens-
Latem, Belgium).
Detection of integrons by PCR and characterisation of gene
cassettes
Integrons were detected by amplification of the integrase genes
of class 1 and 2 integrons (intI1 and intI2) with the Int1F ⁄ Int1R
and Int2F ⁄ Int2R primers [20]. Gene cassettes of strains that
contained intI1 were amplified subsequently with primers
5¢CS and 3¢CS [21], followed by restriction with HaeIII, TaqaI
and MseI (New England Biolabs, Leusden, The Netherlands)
according to the manufacturer’s recommendations. The result-
Table 1. Drug susceptibility patterns and the presence of integrase genes in 161 Escherichia coli isolates from two hospitals
in The Netherlands
Ciprofloxacin Co-trimoxazole Gentamicin Amoxycillin
Haematology wards Other wards
No. of
isolates
Integrase gene
No. of
isolates
Integrase gene
I II I/II None I II I/II None
R R R R 15 12 – 3 – 4 3 – – –
R R R S 2 2 – – – 1 1 – – –
R R S R 30 25 2 1 2 17 14 3 – –
R R S S 2 1 – – 1 1 – 1 – –
R S R R 1 – – – 1 1 1 – – 1
R S S R 1 – – – 1 3 2 – – 1
R S S S 3 – – – 3 1 – – – 1
S R R R 1 1 – – – – – – – –
S R S R 5 3 1 – 1 – – – – –
S R S S 3 1 1 – 1 – – – – –
S S S R 11 3 1 1 6 – – – – –
S S S S 59 – 8 – 51 – – – – –
Total 133 48 13 5 67 28 21 4 0 3
R, resistant; S, susceptible (according to NCCLS criteria [17]).
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ing DNA fragments were separated by electrophoresis at
100 V for 2 h on agarose 1.5% w ⁄v gels, stained with ethidium
bromide and visualised under UV light.
Restriction fragment length polymorphism (RFLP) patterns
were analysed by visual examination. Identical RFLP patterns
were considered to be indicative of identical gene cassettes,
and consequently the respective E. coli isolates were consid-
ered to contain identical integrons. One representative gene
cassette of each RFLP type was sequenced on an automated
sequencer (ABI Prism 3100) with a Big Dye Terminator Kit III
(Applied Biosystems) in accordance with the manufacturer’s
recommendations.
Detection of the qnr quinolone resistance gene
The presence of qnr was detected by dot-blot experiments. The
qnr probe was amplified from E. coli J53 (pMG252) [10], and
was labelled with the PCR DIG Probe synthesis kit (Roche
Diagnostics). Denatured total DNA was spotted on to posi-
tively charged nylon membranes, and then exposed to
1.5 J ⁄ cm2 UV irradiation (Polyvalent UV 254-nm system;
Syngene, Leusden, The Netherlands) to immobilise the DNA.
Following hybridisation, colourimetric DIG detection was
performed according to the instructions from the manufac-
turer. E. coli J53 pMG252 was included in this assay as a
positive control.
Analysis of the gyrA gene
Specific PCR primers (5¢-TAATCACCGGTACACCGTCG-
CGTA and 5¢-TAGGATCCGTCGCCGTCGATAGAA) were
designed to amplify the quinolone resistance-determining
region of gyrA. PCR conditions comprised 94C for 3 min,
followed by 35 cycles of 94C for 30 s, 60C for 30 s and 72C
for 1 min, and then 72C for 10 min. The resulting PCR
products were sequenced (ABI Prism 3100) with the Big Dye
Terminator Kit III in accordance with the manufacturer’s
recommendations.
Conjugation
Conjugation experiments were performed on membrane filters
with a rifampicin-resistant E. coli cc118kpir strain as recipient.
Broth cultures of donor (see Results) and recipient cells in
the logarithmic phase were mixed and incubated on an
MF-Millipore membrane filter (Millipore, Bedford, MA, USA)
on Luria–Bertani (LB) agar for c. 6 h at 37C. Subsequently, the
cells were resuspended in 5 mL of phosphate-buffered saline
and transconjugants were selected on LB agar plates contain-
ing rifampicin (10 mg ⁄L) and sulphamethoxazole (20 mg ⁄L).
MICs of ciprofloxacin for the donor, recipient and transcon-
jugant strains were measured by microtitre broth dilution.
RESULTS
The frequencies of the different susceptibility
patterns for the 161 isolates are shown in Table 1.
DNA fingerprinting by AFLP showed that the
isolates were heterogeneous, thereby excluding
clonal spread of one particular ciprofloxacin-
resistant E. coli strain.
Of the 54 ciprofloxacin-resistant E. coli isolates
from haematology wards, 44 (81%) contained
intI1, compared with nine (10%) of 79 ciprofloxa-
cin-susceptible isolates. Of 28 ciprofloxacin-resist-
ant isolates from other wards, 21 (75%) harboured
a class 1 integron structure. The intI1 gene was
detected in ciprofloxacin-resistant E. coli isolates
from both hospitals (19 (90%) of 21 isolates from
patients in Amsterdam, and 25 (75%) of 33
isolates from patients in Rotterdam), and was
associated significantly with resistance to each of
the antibiotics tested (Fisher’s exact test;
p < 0.0001). Binary logistic regression was used
to determine that the resistances associated
independently and most strongly with the pre-
sence of class 1 integrons were for co-trimoxazole
(p 0.001) and amoxycillin (p 0.001).
Various sizes (1.0, 1.5 and 3.0 kb) of class 1
integron gene cassettes were identified. No anti-
biotic resistance gene cassette was detected in
nine (12%) of the 74 E. coli isolates that contained
intI1.
To determine whether the integrons varied in
gene content, the gene cassettes were analysed by
PCR-RFLP. Four frequently occurring PCR-RFLP
gene cassettes were designated as class 1 integron
gene cassette types A, B, C and D. Types A and B
were present in 26 (35%) and 18 (24%) of the 74
isolates, respectively, while types C and D were
both present in seven (9%) isolates. Seven (9%)
isolates contained gene cassettes with unique PCR-
RFLP patterns.No differences in the distribution of
gene cassettes A, B, C and D were observed
between isolates from Rotterdam and Amsterdam,
or from haematology and other wards.
In order to identify the genes within the
cassettes, examples of integron class 1 types A,
B, C and D were sequenced. Type A con-
tained dfrA17, encoding dihydrofolate reductase
(trimethoprim resistance) and aadA5, encoding
aminoglycoside 3¢-(9)-O-adenyltransferase (strep-
tomycin and spectinomycin resistance). The gene
sequences of integron class 1 type A were
identical to the integron sequence of GenBank
accession no. AY139591, while sequences of type
B were homologous to the integron sequence of
GenBank accession no. AJ419168. Integron type B
contained dfrI and aadA. Only aadA1, encoding
aminoglycoside 3¢-(9)-O-adenyltransferase, was
present in the gene cassettes of integron type C
(GenBank accession no. AF205943), while dfhr12
900 Clinical Microbiology and Infection, Volume 11 Number 11, November 2005
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11, 898–902
and aadA2 were present in integron type D
(GenBank accession no. AF335108). The presence
of qnrA (GenBank accession no. AY070235) [8–10]
was investigated by dot-blot hybridisation, but
none of the isolates tested contained qnrA.
The sequences of the quinolone resistance-
determining region of gyrA in 39 ciprofloxacin-
susceptible and 39 resistant isolates were analysed
by comparison with the published genome
sequence of E. coli K12 [22]. Two of 39 susceptible
isolates had a mutation in gyrA, which resulted in
a single amino-acid change, S83L. All 39 cipro-
floxacin-resistant isolates carried an identical
alteration in amino-acid 83. In addition, 29 of
these isolates also had an alteration in amino-acid
87, most commonly D87N (23 isolates), followed
by D87Y (five isolates); D87G was found in only
one isolate. Statistical analysis (Fisher’s exact test)
showed that there was a significant association
(p < 0.0001) between ciprofloxacin resistance and
one or more mutations in gyrA.
Conjugation experiments were performed with
a clinical isolate from a patient in the haematology
department of the Erasmus University Medical
Center. This isolate harboured a class 1 integron
containing gene cassette type D (present in seven
of 65 ciprofloxacin-resistant isolates that con-
tained intI1) and was resistant to ciprofloxacin,
gentamicin and co-trimoxazole. The results indi-
cated that gentamicin, tobramycin and co-trim-
oxazole resistances were co-transferred with the
integron structure, while ciprofloxacin resistance
was not. The ciprofloxacin MIC for the donor
strain was 64 mg ⁄L, compared with 0.125 mg ⁄L
for the transconjugant and recipient strains.
DISCUSSION
AFLP analysis of isolates showed that the increase
in ciprofloxacin resistance was not caused by
clonal spread of a single ciprofloxacin-resistant
strain, in contrast with an increase in multidrug
resistance associated with the spread of a single
clone over two vast regions in the USA [23–25].
However, the presence of class 1 integrons was
associated significantly with ciprofloxacin,
co-trimoxazole, amoxycillin and gentamicin
resistance in the E. coli isolates. Although the
latter associations are well-established, the associ-
ation of ciprofloxacin resistance with the presence
of a class 1 integron is unusual [6,26], although it
has been reported previously by Leverstein-Van
Hall et al. [3], Martinez-Freijo et al. [4] and Van
Belkum et al. [6]. However, the basis for this
association is unknown.
Characterisation of the gene cassettes revealed
that the 74 isolates positive for intI1 harboured
four different gene cassettes (types A, B, C and
D) and two functionally different antibiotic
resistance genes encoding trimethoprim and
streptomycin ⁄ spectomycin resistance. No evi-
dence was found within the gene cassettes to
indicate integron-associated resistance to amoxy-
cillin, gentamicin or ciprofloxacin. None of the
integrons contained qnrA, and qnrA was not
present in any of these isolates according to dot-
blot analysis, thereby excluding the possibility
that the gene was present, but not located
within the integron gene cassettes. In addition,
conjugation experiments revealed that cipro-
floxacin resistance was not co-transferred with
the integron to a recipient E. coli strain. Taken
together, these results rendered transferable
quinolone resistance an unlikely explanation
for the observed increase in the isolation rate
of ciprofloxacin-resistant E. coli isolates on the
two haematology wards. Although a statistical
association between ciprofloxacin resistance and
the presence of an integron was demonstrated,
no genetic determinants responsible for this
association were identified.
Resistance to fluoroquinolones in E. coli is
caused primarily by chromosomal mutations in
the genes encoding DNA gyrase and topoisom-
erase IV [27], especially the GyrA subunit of DNA
gyrase. Sequencing of gyrA in the present study
revealed that mutations at positions 83 or 87, or
both, were associated significantly with cipro-
floxacin resistance. These mutations are consid-
ered to be the most important modifications in E.
coli leading to resistance to fluoroquinolones [15].
Thus, resistance to ciprofloxacin in this strain
collection could be explained fully by mutations
in genes coding for DNA gyrase and topoiso-
merase IV.
Support was not found for the hypothesis of a
genetic association between ciprofloxacin resist-
ance and class 1 integrons [1,4,6]. It has been
observed previously [2] that integrons are wide-
spread among Enterobacteriaceae in the commu-
nity in The Netherlands. It is suggested that the
increase in the isolation frequency of ciprofloxa-
cin-resistant E. coli in these patient groups is
caused by a combination of increased spread of
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integron structures within the community and
selective antibiotic pressure associated with
ciprofloxacin regimens in the hospitals.
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